Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Nilvadipine is a calcium channel blocker used to manage arterial hypertension. A drug used to treat high blood pressure.
- Mechanism
- Curator reviewed
Nilvadipine inhibits the influx of extracellular calcium through myocardial and vascular membrane pores by physically plugging the channel. The decrease in intracellular calcium inhibits the contractile processes of smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.
- Primary indication
- For the management of vasospastic angina, chronic stable angina and hypertension.Curator reviewed · 1 structured indication
- Formula / weight
- C19H19N3O6 · 385.3707 g/mol (avg)
- Code names
- CL 287,389 · FK 235 · FR-34235 · SK&F 102,362
Resolves to
FAIIFDPAEUKBEP-UHFFFAOYSA-NSMILESCOC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#NWhat you can answer from here — as of August 25, 2026
Which drugs share a target with Nilvadipine, and which of those have an active Phase 3 trial?